Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension

Documenti analoghi

• The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension
  di: Falk, Jeremy A, et al.
  Pubblicazione: (2010)
• Switching from Nitrate Therapy to Ranolazine in Patients with Coronary Artery Disease Receiving Phosphodiesterase Type-5 Inhibitors for Erectile Dysfunction
  di: Udeoji, Dioma U, et al.
  Pubblicazione: (2014)
• Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
  di: Sitbon, Olivier, et al.
  Pubblicazione: (2020)
• Effects of macitentan and tadalafil monotherapy or their combination on the right ventricle and plasma metabolites in pulmonary hypertensive rats
  di: Mamazhakypov, Argen, et al.
  Pubblicazione: (2020)
• Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based review
  di: Henrie, Adam M, et al.
  Pubblicazione: (2015)